DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vyvanse (Lisdexamfetamine) - Completed Suicide - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Completed Suicide ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vyvanse (Lisdexamfetamine) where reactions include completed suicide. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vyvanse side effects in 10 year old female

Reported by a consumer/non-health professional from United States on 2012-02-17

Patient: 10 year old female, weighing 45.4 kg (99.8 pounds)

Reactions: Completed Suicide

Adverse event resulted in: death

Drug(s) suspected as cause:
Vyvanse



Possible Vyvanse side effects in 10 year old female

Reported by a consumer/non-health professional from United States on 2012-02-08

Patient: 10 year old female

Reactions: Completed Suicide

Adverse event resulted in: death

Drug(s) suspected as cause:
Vyvanse



Possible Vyvanse side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-12

Patient: 10 year old female

Reactions: Completed Suicide

Adverse event resulted in: death

Drug(s) suspected as cause:
Vyvanse



Possible Vyvanse side effects in 16 year old male

Reported by a consumer/non-health professional from United States on 2011-11-10

Patient: 16 year old male

Reactions: Completed Suicide

Adverse event resulted in: death

Drug(s) suspected as cause:
Vyvanse



Possible Vyvanse side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-27

Patient: female

Reactions: Completed Suicide

Adverse event resulted in: death

Drug(s) suspected as cause:
Vyvanse



Possible Vyvanse side effects in 7 year old male

Reported by a physician from United States on 2011-10-06

Patient: 7 year old male, weighing 30.4 kg (66.9 pounds)

Reactions: Completed Suicide, Abnormal Behaviour, Impulsive Behaviour, Aggression

Adverse event resulted in: death

Drug(s) suspected as cause:
Symbyax
    Dosage: 3mg/25mg (1 in 1 d),
    Indication: Aggression
    Start date: 2009-03-18
    End date: 2009-04-16

Symbyax
    Dosage: 3mg/25mg (1 in 1 d),
    Indication: Impulsive Behaviour
    Start date: 2009-03-18
    End date: 2009-04-16

Lexapro
    Dosage: 5 mg (5 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2009-02-03
    End date: 2009-03-18

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2009-03-31
    End date: 2009-04-16

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2009-03-31
    End date: 2009-04-16

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2008-12-09
    End date: 2009-03-30

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2008-12-09
    End date: 2009-03-30

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014